Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 312

1.

Metabolism, lifestyle and bipolar affective disorder.

Morriss R, Mohammed FA.

J Psychopharmacol. 2005 Nov;19(6 Suppl):94-101. Review.

PMID:
16280342
2.

Bipolar disorder and diabetes mellitus: epidemiology, etiology, and treatment implications.

McIntyre RS, Konarski JZ, Misener VL, Kennedy SH.

Ann Clin Psychiatry. 2005 Apr-Jun;17(2):83-93. Review.

PMID:
16075661
3.

Health and mortality consequences of abdominal obesity: evidence from the AusDiab study.

Cameron AJ, Dunstan DW, Owen N, Zimmet PZ, Barr EL, Tonkin AM, Magliano DJ, Murray SG, Welborn TA, Shaw JE.

Med J Aust. 2009 Aug 17;191(4):202-8.

PMID:
19705980
4.
5.

Associations between bipolar disorder and metabolic syndrome: A review.

Taylor V, MacQueen G.

J Clin Psychiatry. 2006 Jul;67(7):1034-41. Review.

PMID:
16889445
6.

Metabolic and lifestyle issues and severe mental illness--new connections to well-being?

[No authors listed]

J Psychopharmacol. 2005 Nov;19(6 Suppl):188-22. No abstract available.

PMID:
19886294
7.

Challenges in advancing mental and physical health of patients with serious mental illness.

Dursun S, Dinan TG, Bushe C, Thakore J.

J Psychopharmacol. 2005 Nov;19(6 Suppl):3-5. No abstract available.

PMID:
16280332
8.

Metabolic syndrome and mental illness.

Newcomer JW.

Am J Manag Care. 2007 Nov;13(7 Suppl):S170-7. Review. Erratum in: Am J Manag Care. 2008 Feb;14(2):76.

9.

Development of a health screening clinic.

Millar HL.

Eur Psychiatry. 2010 Jun;25 Suppl 2:S29-33. doi: 10.1016/S0924-9338(10)71703-X.

PMID:
20620883
10.

Bipolar disorder, obesity, and pharmacotherapy-associated weight gain.

Keck PE, McElroy SL.

J Clin Psychiatry. 2003 Dec;64(12):1426-35. Review.

PMID:
14728103
11.

Study protocol for a systematic review of evidence for lifestyle interventions targeting smoking, sleep, alcohol/other drug use, physical activity, and healthy diet in people with bipolar disorder.

Kay-Lambkin FJ, Thornton L, Lappin JM, Hanstock T, Sylvia L, Jacka F, Baker AL, Berk M, Mitchell PB, Callister R, Rogers N, Webster S, Dennis S, Oldmeadow C, MacKinnon A, Doran C, Turner A, Hunt S.

Syst Rev. 2016 Jul 5;5(1):106. doi: 10.1186/s13643-016-0282-9. Review.

12.

Long-term health considerations in schizophrenia: metabolic effects and the role of abdominal adiposity.

Van Gaal LF.

Eur Neuropsychopharmacol. 2006 Sep;16 Suppl 3:S142-8. Epub 2006 Jul 24. Review.

PMID:
16863690
13.

Age-specific prevalence of metabolic syndrome in Italian patients with bipolar disorder.

Salvi V, D'Ambrosio V, Rosso G, Bogetto F, Maina G.

Psychiatry Clin Neurosci. 2011 Feb;65(1):47-54. doi: 10.1111/j.1440-1819.2010.02160.x.

14.

Medical risk in patients with bipolar disorder and schizophrenia.

Newcomer JW.

J Clin Psychiatry. 2006;67 Suppl 9:25-30; discussion 36-42. Review.

15.

Dyslipidemia in the metabolic syndrome in children.

Gidding SS.

J Cardiometab Syndr. 2006 Summer;1(4):282-5. Review.

17.

Challenges and strategies in managing cardiometabolic risk.

Repas TB.

J Am Osteopath Assoc. 2007 Apr;107(4 Suppl 2):S4-11. Review.

PMID:
17784529
18.

Treatment decisions in major mental illness: weighing the outcomes.

Vreeland B.

J Clin Psychiatry. 2007;68 Suppl 12:5-11.

19.

Metabolic syndrome in Italian patients with bipolar disorder.

Salvi V, Albert U, Chiarle A, Soreca I, Bogetto F, Maina G.

Gen Hosp Psychiatry. 2008 Jul-Aug;30(4):318-23. doi: 10.1016/j.genhosppsych.2008.04.009.

PMID:
18585534
20.

Medical risk in patients with bipolar disorder and schizophrenia.

Newcomer JW.

J Clin Psychiatry. 2006 Nov;67(11):e16.

Supplemental Content

Support Center